Integrated flow-through purification for therapeutic monoclonal antibodies processing

ABSTRACT An integrated all flow-through technology platform for the purification of therapeutic monoclonal antibodies (mAb), consisting of activated carbon and flow-through cation and anion exchange chromatography steps, can replace a conventional chromatography platform. This new platform was observed to have excellent impurity clearance at high mAb loadings with overall mAb yield exceeding 80%. Robust removal of DNA and host cell protein was demonstrated by activated carbon and a new flow-through cation exchange resin exhibited excellent clearance of mAb aggregate with high monomer recoveries. A ten-fold improvement of mAb loading was achieved compared to a traditional cation exchange resin designed for bind and elute mode. High throughput 96-well plate screening was used for process optimization, focusing on mAb loading and solution conditions. Optimum operating windows for integrated flow-through purification are proposed based on performance characteristics. The combination of an all flow-through polishing process presents significant opportunities for improvements in facility utilization and process economics.

[1]  K. Walker,et al.  Automated two-step chromatography using an ÄKTA equipped with in-line dilution capability. , 2015, Journal of chromatography. A.

[2]  Harry Marsh,et al.  CHAPTER 2 – Activated Carbon (Origins) , 2006 .

[3]  Alex Xenopoulos,et al.  A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies. , 2015, Journal of biotechnology.

[4]  Alois Jungbauer,et al.  Continuous downstream processing of biopharmaceuticals. , 2013, Trends in biotechnology.

[5]  Mikhail Kozlov,et al.  Separating proteins with activated carbon. , 2014, Langmuir : the ACS journal of surfaces and colloids.

[6]  Sanchayita Ghose,et al.  Pool‐less processing to streamline downstream purification of monoclonal antibodies , 2017, Engineering in life sciences.

[7]  Kelly A. Coughlin,et al.  Monoclonal antibody fragment removal mediated by mixed mode resins. , 2017, Journal of chromatography. A.

[8]  H. Chase,et al.  Prediction of the performance of preparative affinity chromatography. , 1984, Journal of chromatography.

[9]  Brian Kelley,et al.  Very Large Scale Monoclonal Antibody Purification: The Case for Conventional Unit Operations , 2007, Biotechnology progress.

[10]  Christopher Gillespie,et al.  Integrating Continuous and Single‐Use Methods to Establish a New Downstream Processing Platform for Monoclonal Antibodies , 2014 .

[11]  Sanchayita Ghose,et al.  Purification of monoclonal antibodies by hydrophobic interaction chromatography under no-salt conditions , 2013, mAbs.

[12]  Brian Hubbard,et al.  Downstream processing of monoclonal antibodies--application of platform approaches. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  M. Schofield,et al.  Transfer of a three step mAb chromatography process from batch to continuous: Optimizing productivity to minimize consumable requirements. , 2017, Journal of biotechnology.

[14]  Scott M Husson,et al.  Anion exchange membrane adsorbers for flow‐through polishing steps: Part II. Virus, host cell protein, DNA clearance, and antibody recovery , 2013, Biotechnology and bioengineering.

[15]  T. Arakawa,et al.  Developments and Challenges for mAb-Based Therapeutics , 2013 .

[16]  André Kiesewetter,et al.  Cation exchange chromatography in antibody purification: pH screening for optimised binding and HCP removal. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  Charles L. Cooney,et al.  White Paper on Continuous Bioprocessing , 2014 .

[18]  Konstantin Konstantinov,et al.  End-to-end integrated fully continuous production of recombinant monoclonal antibodies. , 2015, Journal of biotechnology.

[19]  R. Bayer,et al.  Recovery and purification process development for monoclonal antibody production , 2010, mAbs.

[20]  Jochen Strube,et al.  Challenges in biotechnology production—generic processes and process optimization for monoclonal antibodies , 2005 .

[21]  P A Marichal-Gallardo,et al.  State‐of‐the‐art in downstream processing of monoclonal antibodies: Process trends in design and validation , 2012, Biotechnology progress.

[22]  J. Chon,et al.  Advances in the production and downstream processing of antibodies. , 2011, New biotechnology.

[23]  Daniel G Bracewell,et al.  Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture. , 2013, Journal of chromatography. A.

[24]  Andrew L. Zydney,et al.  Perspectives on integrated continuous bioprocessing — opportunities and challenges , 2015 .

[25]  Jason Walther,et al.  The business impact of an integrated continuous biomanufacturing platform for recombinant protein production. , 2015, Journal of biotechnology.

[26]  Neil P. Soice,et al.  Cored anion-exchange chromatography media for antibody flow-through purification. , 2007, Journal of chromatography. A.

[27]  Giorgio Carta,et al.  Separation of antibody monomer-dimer mixtures by frontal analysis. , 2017, Journal of chromatography. A.

[28]  John Sherbondy.  Activated carbon , 2019, Carbon Materials.

[29]  J. Coffman,et al.  A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode , 2013, Biotechnology and bioengineering.

[30]  Giorgio Carta,et al.  Adsorption equilibrium and kinetics of monomer-dimer monoclonal antibody mixtures on a cation exchange resin. , 2015, Journal of chromatography. A.

[31]  Eric J. Suda,et al.  Comparison of agarose and dextran-grafted agarose strong ion exchangers for the separation of protein aggregates. , 2009, Journal of chromatography. A.

[32]  Konstantin B Konstantinov,et al.  White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium. , 2015, Journal of pharmaceutical sciences.

[33]  Jemelle Dizon-Maspat,et al.  Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production , 2012, Biotechnology and bioengineering.

[34]  Daniel Cummings,et al.  Integrated continuous production of recombinant therapeutic proteins , 2012, Biotechnology and bioengineering.

[35]  H. Chase,et al.  Comparison of diffusion and diffusion-convection matrices for use in ion-exchange separations of proteins. , 1998, Journal of chromatography. A.